Payoneer Global opened lower at $7.15, compared with its previous close of $7.16. In the last trading session, the stock traded between $7.14 and $7.18. It showed a sideways intraday trend.
An investment of $100 made 5 years ago in Payoneer Global is now worth
$ 83.24
Resulting in a loss of
$ 16.76 (16.76%)
Note: Past profits do not guarantee future returns.
Rating from 1 Analysts
Today's Change
+$0.02 (+0.21%)
Day High
$7.18
Day Low
$7.14
Day Open
$7.15
Prev Close
$7.16
Volume
56,59,256
1W Return
-0.32%
1M Return
0.56%
3M Return
1.27%
6M Return
40.41%
1Y Return
27.44%
Market Cap ($ Mn)
2,446
PE Ratio
50.79
PB Ratio
3.69
PEG Ratio
0.98
ROE
9.89%
ROCE
-12.46%
EPS (TTM)
$0.04
1 Week
-0.32%
1 Month
0.56%
3 Months
1.27%
6 Months
40.41%
9 Months
21.82%
Law firm probes Payoneer, Bio-Techne, Colony Bankcorp shareholder deals
Halper Sadeh LLC is probing potential fiduciary breaches in deals involving Payoneer Global Inc., Bio-Techne Corporation, and Colony Bankcorp, Inc. The investigation questions whether shareholders received fair value in the sales of Payoneer to Nuvei ($7.40/share) and Bio-Techne to Merck KGaA ($73.00/share), as well as the Colony Bankcorp merger. Shareholders are invited to join the potential class action on a contingent fee basis.
2mo agoAdemi LLP Investigates Payoneer Global's $2.75 Billion Transaction with Nuvei Over Fiduciary Duty Concerns
Ademi LLP is investigating Payoneer Global Inc.'s transaction with Nuvei for possible breaches of fiduciary duty, focusing on whether the board is acting in the best interests of all public shareholders. Payoneer stockholders are set to receive $7.40 per share in cash, with the deal carrying a total transaction equity value of approximately $2.75 billion. The firm also scrutinizes deal provisions that allegedly impose penalties on competing bids and the substantial benefits extended to Payoneer insiders through change of control arrangements. Shareholders may join the investigation at no cost by contacting Ademi LLP directly.
4mo agoBenchmark downgrades Payoneer Global from Buy to Hold
Benchmark analyst Mark Palmer has downgraded Payoneer Global from Buy to Hold, adjusting the investment stance on the NASDAQ-listed stock.
4mo agoWohl & Fruchter investigates Payoneer sale to Nuvei
Wohl & Fruchter LLP has launched an investigation into the proposed acquisition of Payoneer Global Inc. by Nuvei for $7.40 per share in cash. The firm is scrutinizing the fairness of the offer and the sales process, suggesting the price may not reflect the company's value given recent strategic developments. These include Payoneer's authorization to operate as a Payment Aggregator in India and its application for a US national trust bank charter. The transaction, valued at $2.75 billion, is expected to close in mid-2027 and will create a combined entity projecting $3 billion in annual revenue.
4mo agoCitigroup downgrades Payoneer Global to Neutral, cuts target to $7.4
Citigroup analyst Peter Christiansen has downgraded Payoneer Global from Buy to Neutral, lowering the price target to $7.4 from $10.
4mo agoWilliam Blair downgrades Payoneer Global to Market Perform
William Blair analyst Cristopher Kennedy downgraded Payoneer Global from Outperform to Market Perform, adjusting the investment outlook on the NASDAQ-listed company.
5mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $521.13 | -2.26% | $38,69,975.87M | 28.61 | |
| $172.40 | +2.12% | $3,97,675.94M | 160.64 | |
| $128.38 | +8.82% | $3,88,187.23M | 25.87 | |
| $234.10 | +0.15% | $2,87,592.79M | 28.43 | |
| $334.47 | +2.49% | $2,73,854.67M | 323.12 | |
| $248.22 | +1.51% | $2,34,597.93M | 20.94 | |
| $229.06 | +1.46% | $2,34,542.55M | 3,970.91 | |
| $149.26 | +1.81% | $1,80,374.29M | 103.31 | |
| $218.01 | +2.12% | $1,79,422.23M | 23.42 | |
| $253.66 | -1.88% | $1,49,846.35M | 15.14 | |
| $70.68 | +0.90% | $1,44,321.35M | 17.29 | |
| $306.36 | +0.30% | $1,20,938.37M | 26.28 |
An investment of $100 made 5 years ago in Payoneer Global is now worth
$ 83.24
Resulting in a loss of
$ 16.76 (16.76%)
Note: Past profits do not guarantee future returns.
